Chris Cline
Direttore Finanziario/CFO presso TRAVERE THERAPEUTICS, INC.
Patrimonio netto: 582 379 $ in data 30/06/2024
Profilo
Chris Cline is currently a Member at the National Investor Relations Institute.
He is also currently serving as the Chief Financial Officer at Travere Therapeutics, Inc. since 2014.
Mr. Cline completed his undergraduate degree at Williams College of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 11/04/2024 | 70 849 ( 0.09% ) | 582 379 $ | 30/06/2024 |
Posizioni attive di Chris Cline
| Società | Posizione | Inizio |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 31/08/2022 |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Chris Cline
| Società | Posizione | Fine |
|---|---|---|
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | 01/02/2014 |
Phase Forward, Inc.
 Phase Forward, Inc. Packaged SoftwareTechnology Services Phase Forward, Inc. developed e-process software solutions for accelerating global pharmaceutical development. The company was founded by Paul A. Bleicher and Augustine in 1997 and was headquartered in Waltham, MA. | Corporate Officer/Principal | - |
Formazione di Chris Cline
| Williams College of Business | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TRAVERE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Phase Forward, Inc.
Phase Forward, Inc. Packaged SoftwareTechnology Services Phase Forward, Inc. developed e-process software solutions for accelerating global pharmaceutical development. The company was founded by Paul A. Bleicher and Augustine in 1997 and was headquartered in Waltham, MA. | Technology Services |
- Borsa valori
- Insiders
- Chris Cline
